Data is collected as part of clinical research projects in order to meet the aims and answer the research questions of a particular project. For the majority of LCTC managed projects, LCTC acts as the Custodian of this data on behalf of the project's Sponsor and Data Controller organisations.

The societal benefit of using data collected as part of a specific research study for wider research purposes is widely recognised and indeed is a requirement of many funding bodies (including UKRI funders), medical journals and the University of Liverpool. As such, data held by the LCTC may be shared with approved third-party researchers, subject to all appropriate legislative and ethical requirements being confirmed.

The decision to share data is taken by the original project's Sponsor and Data Controller organisations. Approved requests are facilitated by LCTC where we hold the data. This webpage provides details on data sharing activities facilitated by LCTC.

Data Sharing Activity

Original Project Name	Link to original project LCTC webpage	Requester project name	Requester organisation	Data sharing decision	Date data shared (if applicable)
ESPAC-3 (as part of ESPAC-Tplus)	https://www.lctc.org.uk/research/espac-3-espac-3-v2/ & https://www.lctc.org.uk/research/espac-tplus/	Treatment stratification signatures (TSS) that identify best responders to 5-fluorouracil as well as gemcitabine based therapy, and oxaliplatin based therapy in patients with pancreatic ductal adenocarcinoma (PDAC) - Prof. John Neoptolemos	University of Heidelberg	APPROVED	06 May 2021
ESPAC-4 (as part of ESPAC-Tplus)	https://www.lctc.org.uk/research/espac-4/ & https://www.lctc.org.uk/research/espac-tplus/	Treatment stratification signatures (TSS) that identify best responders to 5-fluorouracil as well as gemcitabine based therapy, and oxaliplatin based therapy in patients with pancreatic ductal adenocarcinoma (PDAC) - Prof. John Neoptolemos	University of Heidelberg	APPROVED	06 May 2021